Genedata Biologics® brings biotherapeutic research to the next level by integrating all discovery workflows. The most widely adopted workflow platform across the industry, it allows users to focus on true innovation.
IO, CAR-Ts, hybridoma, B-cells—reduce R&D process complexity across discovery applications
Screening, engineering, production—a modular platform for the entire discovery workflow
From deployment to supporting new biologics R&D processes—our scientific advisors are ready to help
We're helping companies around the world transform discovery operations—hear their stories
One of the reasons we chose Genedata Biologics was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
Sergio Rotstein, Ph.D. Director of Research Business Technology
We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types across Genmab’s discovery and clinical workflows.
Hisham Hamadeh, Ph.D. VP, Global Head of Data Sciences
We chose Genedata Biologics because its built-in business logic avoids costly software customization and it’s a proven off-the-shelf-product that can be implemented quickly and replace our current processes.
We made a decision early on to use Genedata Biologics as MorphoSys’ workflow backbone to accelerate our drug discovery efforts and have watched as Genedata Biologics has become the global industry standard for biopharma discovery organizations.
Markus Enzelberger, Ph.D. Senior VP and Head of Discovery, Alliances and Technologies
Genedata Biologics will be our central repository for mission-critical data on therapeutic candidates such as bioactivity, developability, and manufacturability, and will enable transparent decision-making on candidates to move forward.
Bjoern Hock, Ph.D. Director, Global Head Protein Engineering and Antibody Technologies
Accelerate research with a first-in-class platform uniquely designed from the start to digitalize biotherapeutic discovery. The platform facilitates complex R&D processes by designing, tracking, testing, and assessing novel biotherapeutics drugs. It works with any format, from antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, to engineered therapeutic cell lines such as TCRs and CAR-T cells.
E2E. A Next-Generation Platform.
Acting as a central end-to-end data backbone, Genedata Biologics integrates all R&D processes, from library design and immunizations, selections and panning, molecular biology, screening, protein engineering, expression, purification, and protein analytics, to candidate developability and manufacturability assessments. With its scalable and modular architecture, it fully automates the discovery process and manages the highest data volumes. As a shared platform, it facilitates collaboration among different sites and groups and external partners such as CROs. Real-time access to all relevant data enables users at all levels of an organization to rapidly make more informed decisions, as well as analyze data patterns to drive future discovery programs.
Less Tedious Daily Work.
Genedata Biologics dramatically simplifies all day-to-day laboratory activities such as cloning, screening, expression, purification, and sample management and automates all data upload, data processing, and reporting. Direct integration with laboratory instruments and robotics stations enables true high-throughput processes. Customers report more than 50% gains in efficiency and improved quality of results.
Providing a central and shared platform, Genedata Biologics gives every R&D team access to all discovery program information for any project at any time. This makes it possible to simultaneously investigate across projects to track program progress and optimize resource usage to improve R&D forecasting, reduce costs, and improve overall productivity.